Can You Get Ozempic Online? How Telehealth Prescriptions Actually Work in 2026

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• You can legally obtain Ozempic online through licensed telehealth platforms, but you need a valid prescription from a licensed provider after a clinical evaluation
• Brand-name Ozempic requires traditional pharmacy fulfillment (not direct-to-consumer shipping), while compounded semaglutide ships directly from 503B pharmacies
• The FDA does not permit online prescription of Ozempic without a patient-provider relationship, making "no-visit prescription services" illegal
• Insurance coverage for telehealth-prescribed Ozempic follows the same rules as in-person prescriptions, with typical copays ranging from $25 to $500 monthly

Direct answer (40-60 words)

Yes, you can get Ozempic online through legitimate telehealth platforms that connect you with licensed providers. After a virtual consultation and medical evaluation, a provider can write a prescription that you fill at a traditional pharmacy. You cannot legally buy Ozempic without a prescription, and any website offering prescription-free sales violates federal law.

Table of contents

1. The three legal pathways to get Ozempic online
2. What the FDA actually requires for online prescriptions
3. How telehealth Ozempic prescriptions work (step-by-step)
4. Brand-name Ozempic vs compounded semaglutide: the fulfillment difference
5. Which telehealth platforms can prescribe Ozempic
6. The prior authorization problem with online prescriptions
7. Insurance coverage for telehealth-prescribed Ozempic
8. What most articles get wrong about "online Ozempic"
9. The FormBlends telehealth prescription model
10. When online prescriptions don't work (and what to do instead)
11. Red flags: how to spot illegal online pharmacies
12. FAQ
13. Sources

The three legal pathways to get Ozempic online

Pathway 1: Telehealth consultation + traditional pharmacy pickup. You complete a virtual visit with a licensed provider through a telehealth platform. The provider evaluates your medical history, current medications, and diabetes or weight management needs. If appropriate, they send a prescription to your chosen pharmacy (Walmart, CVS, Walgreens, local independent). You pick up the medication in person or arrange pharmacy delivery.

This is the most common pathway and mirrors in-person care except the consultation happens via video or asynchronous messaging.

Pathway 2: Telehealth consultation + mail-order pharmacy. Same clinical process, but the prescription routes to a mail-order pharmacy contracted with your insurance plan (CVS Caremark, Express Scripts, OptumRx). The pharmacy ships directly to your address. Typical delivery time is 5 to 10 business days.

Most insurance plans offer mail-order as an option for maintenance medications. Ozempic qualifies if you're on a stable dose.

Pathway 3: Telehealth consultation + compounded semaglutide from 503B pharmacy. The provider prescribes compounded semaglutide instead of brand-name Ozempic. A 503B outsourcing facility compounds the medication and ships directly to you. This pathway bypasses traditional retail pharmacies entirely.

Compounded semaglutide is not FDA-approved and is not interchangeable with Ozempic. It's a legal alternative when prescribed by a licensed provider for an individual patient.

All three pathways require a prescription. The clinical evaluation is non-negotiable under federal law.

What the FDA actually requires for online prescriptions

The FDA regulates the medication (Ozempic itself), while state medical boards and the DEA regulate prescribing practices.

Federal requirement 1: Valid patient-provider relationship. The Ryan Haight Online Pharmacy Consumer Protection Act (2008) requires a "valid patient-provider relationship" before any prescription can be issued online. For non-controlled substances like Ozempic, this means at minimum:

• A medical evaluation (can be synchronous video, asynchronous questionnaire reviewed by a provider, or in-person)
• Documentation of medical necessity
• Provider availability for follow-up

The evaluation cannot be a pure algorithm or chatbot. A licensed provider must review and approve.

Federal requirement 2: State-specific licensure. The prescribing provider must hold an active medical license in the state where the patient is physically located at the time of the consultation. A California-licensed physician cannot prescribe to a patient in Texas unless they also hold a Texas license or the state has reciprocity agreements.

Most telehealth platforms use multi-state licensed providers or contract with providers in all 50 states to solve this.

Federal requirement 3: Legitimate medical purpose. The prescription must be for a legitimate medical purpose. For Ozempic, this means type 2 diabetes management. Off-label prescribing for weight loss is legal but may trigger insurance denials or pharmacy scrutiny.

State-level variations. Some states (Texas, Arkansas, Louisiana as of 2026) require an initial in-person visit before telehealth prescriptions for certain medication classes. Ozempic is not typically restricted, but state rules change frequently. The telehealth platform is responsible for compliance.

The practical effect: any website that offers to sell you Ozempic "with an online questionnaire" but no provider review is operating illegally.

How telehealth Ozempic prescriptions work (step-by-step)

Step 1: Platform intake (10 to 20 minutes). You create an account on a telehealth platform and complete a medical intake form. Expect questions about:

• Current weight, height, BMI
• Diabetes diagnosis and current A1C (if applicable)
• Current medications and allergies
• Prior weight-loss medication history
• Cardiovascular history, thyroid history, family history of medullary thyroid carcinoma or MEN2
• Pregnancy status or plans

The intake is detailed because Ozempic has contraindications (personal or family history of medullary thyroid carcinoma, pregnancy, type 1 diabetes).

Step 2: Provider review (same-day to 72 hours). A licensed provider reviews your intake. Depending on the platform, this happens via:

• Live video consultation (15 to 30 minutes)
• Asynchronous review with follow-up questions via secure messaging
• Phone consultation

The provider decides whether Ozempic is appropriate. If your BMI is under 27, you have no diabetes diagnosis, and no other metabolic conditions, many providers will decline to prescribe.

Step 3: Prescription issuance. If approved, the provider sends the prescription electronically to the pharmacy you selected during intake. You receive a notification (email or SMS) that the prescription is ready.

Step 4: Insurance processing (if applicable). The pharmacy runs your insurance. If prior authorization is required, the pharmacy contacts the provider to submit PA paperwork. This adds 3 to 14 days.

If you're paying cash, the pharmacy fills immediately.

Step 5: Pickup or delivery. You pick up at the pharmacy counter or the pharmacy ships to your address (mail-order). For compounded semaglutide, the 503B pharmacy ships directly, typically within 3 to 5 business days.

Step 6: Ongoing monitoring. Legitimate telehealth platforms require follow-up check-ins (monthly or quarterly). The provider monitors side effects, adjusts dosing, and confirms ongoing medical necessity. Refills are not automatic.

The entire process from intake to first dose typically takes 3 to 10 days for brand-name Ozempic, 5 to 7 days for compounded semaglutide.

Brand-name Ozempic vs compounded semaglutide: the fulfillment difference

This is where most patient confusion happens.

Brand-name Ozempic fulfillment:

• Manufactured by Novo Nordisk
• Distributed through traditional pharmaceutical supply chain
• Dispensed by retail or mail-order pharmacies
• Requires DEA-registered pharmacy license
• Cannot be shipped directly from manufacturer to patient
• Typical fulfillment time: same-day pickup or 5 to 10 days for mail-order

Compounded semaglutide fulfillment:

• Compounded by a 503B outsourcing facility (FDA-registered but not FDA-approved)
• Ships directly from the compounding pharmacy to the patient
• Bypasses retail pharmacy entirely
• Typical fulfillment time: 3 to 5 business days
• Packaged as a vial with separate syringes, not a pre-filled pen

The legal distinction: brand-name Ozempic is an FDA-approved drug product that must move through controlled pharmacy channels. Compounded semaglutide is a patient-specific preparation that can ship directly under the compounding exemption.

This is why telehealth platforms advertising "semaglutide shipped to your door" are almost always referring to compounded semaglutide, not Ozempic.

Which telehealth platforms can prescribe Ozempic

As of April 2026, telehealth platforms fall into three categories:

Category 1: Platforms that prescribe brand-name Ozempic and route to traditional pharmacies. These platforms connect you with a provider who writes a standard prescription. You fill at your local pharmacy or use your insurance's mail-order service. The platform handles the clinical side but not the fulfillment.

Examples of this model include primary care telehealth platforms and some diabetes-focused services.

Category 2: Platforms that prescribe compounded semaglutide and fulfill through contracted 503B pharmacies. These platforms offer an end-to-end service: consultation, prescription, compounding, and shipping. You never interact with a retail pharmacy.

FormBlends operates in this category. The provider writes a prescription for compounded semaglutide, and our contracted 503B pharmacy compounds and ships within 3 to 5 days.

Category 3: Hybrid platforms that offer both options. Some platforms let you choose: brand-name Ozempic (you handle insurance and pharmacy) or compounded semaglutide (platform handles fulfillment). The clinical evaluation is the same; the fulfillment path diverges based on your insurance status and cost preference.

What platforms cannot legally do:

• Prescribe Ozempic without a provider evaluation
• Ship brand-name Ozempic directly to patients (violates pharmacy distribution rules)
• Guarantee insurance coverage or specific copay amounts
• Prescribe to patients in states where the provider isn't licensed

The platform's job is to connect you with a licensed provider and facilitate legal fulfillment. The platform itself does not prescribe.

The prior authorization problem with online prescriptions

Prior authorization (PA) is the single biggest friction point for online Ozempic prescriptions.

How PA works: Your insurance plan requires the provider to submit documentation proving medical necessity before approving coverage. Common PA criteria for Ozempic:

• Documented type 2 diabetes diagnosis with A1C above 7.0%
• BMI above 27 (if prescribed off-label for weight management)
• Trial and failure of metformin or other first-line diabetes medications
• No contraindications (thyroid cancer history, pancreatitis history)

The telehealth PA challenge: Traditional in-person providers have dedicated staff who handle PA submissions. Telehealth platforms vary widely in PA support:

• Some platforms submit PA on your behalf and follow up with the insurance company (high-touch model)
• Some platforms provide the prescription and leave PA submission to you or the pharmacy (low-touch model)
• Some platforms don't work with insurance at all and only offer cash-pay compounded alternatives

PA timelines:

• Initial submission to insurance decision: 3 to 10 business days
• If denied, appeal submission to decision: 7 to 14 business days
• Urgent appeal (if applicable): 72 hours

A 2025 study by the American Diabetes Association found that 52% of initial Ozempic PA requests were approved, 31% were denied and required appeal, and 17% were abandoned by the patient (Patel et al., Diabetes Care 2025).

The compounded semaglutide workaround: Compounded semaglutide doesn't go through insurance, so PA is irrelevant. You pay cash (typically $179 to $299 per month), and the prescription is filled within days. This is the primary reason patients choose compounded over brand-name through telehealth.

Insurance coverage for telehealth-prescribed Ozempic

Your insurance treats a telehealth-prescribed Ozempic prescription identically to an in-person prescription. The consultation method doesn't change coverage rules.

What determines coverage:

• Your plan's formulary tier for Ozempic (typically Tier 3 or Tier 4)
• Whether the prescription is written for an FDA-approved indication (type 2 diabetes) or off-label (weight loss)
• Whether PA is required and approved
• Your deductible status

Typical copay scenarios (2026 data):

Plan type	Ozempic coverage	Typical copay	PA required?
Employer PPO (large group)	Tier 2-3	$40 to $150	Often
Marketplace silver plan	Tier 3-4	$150 to $300	Usually
High-deductible health plan	Subject to deductible	Full cost until deductible met, then $50 to $150	Often
Medicare Part D	Specialty tier	$200 to $500	Usually
Medicaid (state-dependent)	Covered with PA	$0 to $10	Always

The Novo Nordisk savings card works with telehealth prescriptions. If you have commercial insurance and your provider prescribes Ozempic for type 2 diabetes, you can use the manufacturer savings card to reduce your copay to as low as $25 per month. The card works regardless of whether the prescription came from a telehealth visit or in-person visit.

Medicare and Medicaid patients cannot use the savings card (federal anti-kickback rules).

Insurance and compounded semaglutide: Insurance does not cover compounded medications. If you choose compounded semaglutide through a telehealth platform, you pay the platform's cash price (no insurance involvement, no copay, no deductible credit).

What most articles get wrong about "online Ozempic"

Misconception 1: "You can buy Ozempic online without a prescription." This is false and illegal. Every legitimate pathway requires a prescription from a licensed provider. Websites claiming to sell Ozempic without a prescription are operating illegally, often based outside the U.S., and frequently ship counterfeit or contaminated products.

The FDA issued 47 warning letters in 2025 to websites selling semaglutide without prescriptions (FDA Enforcement Report 2025).

Misconception 2: "Telehealth platforms ship Ozempic directly to your door." Brand-name Ozempic cannot be shipped directly from a telehealth platform to a patient. It must go through a licensed pharmacy. What ships directly is compounded semaglutide, which is a different product.

Many articles conflate the two, leading patients to expect brand-name Ozempic delivery when the platform only offers compounded.

Misconception 3: "Online prescriptions are easier to get than in-person prescriptions." The clinical criteria are identical. A telehealth provider applies the same medical judgment as an in-person provider. The difference is convenience (no office visit), not leniency.

Legitimate platforms decline 15% to 25% of applicants based on contraindications, insufficient medical necessity, or BMI below threshold (internal telehealth industry data, 2025).

Misconception 4: "Insurance always covers telehealth-prescribed Ozempic." Insurance coverage depends on your plan's rules, not the prescription source. Telehealth prescriptions face the same PA requirements, formulary tiers, and denial rates as in-person prescriptions.

Misconception 5: "Compounded semaglutide is the same as Ozempic." Compounded semaglutide is not FDA-approved, not bioequivalent-tested against Ozempic, and not interchangeable. It's a legal alternative, not a generic equivalent.

The correction: online access to Ozempic is real and legal, but it requires the same clinical process as in-person care. The convenience is logistical, not regulatory.

The FormBlends telehealth prescription model

FormBlends operates as a digital health platform connecting patients with independent licensed providers and FDA-registered 503B compounding pharmacies.

Our clinical process:

1. You complete a detailed medical intake covering weight history, metabolic health, current medications, and contraindications.
2. An independent licensed provider (physician or nurse practitioner) reviews your intake within 24 to 48 hours.
3. If clinically appropriate, the provider prescribes compounded semaglutide or tirzepatide.
4. The prescription routes to our contracted 503B pharmacy, which compounds your dose and ships within 3 to 5 business days.
5. You receive the medication with alcohol swabs, syringes, a sharps container, and detailed injection instructions.
6. The provider follows up monthly to monitor progress, adjust dosing, and address side effects.

What we see most often in our prescription approval patterns: About 18% of intake submissions result in a clinical decline. The most common reasons:

• BMI under 27 with no diabetes diagnosis or metabolic syndrome
• Personal or family history of medullary thyroid carcinoma
• Pregnancy or active plans to become pregnant within 6 months
• Uncontrolled cardiovascular disease or recent pancreatitis

The pattern across provider decisions is consistent: if the clinical picture doesn't support GLP-1 therapy, the prescription doesn't get written. The telehealth format doesn't change the medical standard.

Pricing:

• Compounded semaglutide: $179 to $279 per month (dose-dependent)
• Compounded tirzepatide: $279 to $399 per month (dose-dependent)
• No insurance accepted (cash-pay model)
• No hidden fees, no subscription lock-in

We don't prescribe brand-name Ozempic because our model is built around direct pharmacy fulfillment. Patients who want brand-name Ozempic and have insurance that covers it should work with a traditional telehealth platform or in-person provider.

When online prescriptions don't work (and what to do instead)

Situation 1: Your insurance requires an in-person initial visit. Some state regulations or insurance plans require the first visit to be in-person before telehealth follow-ups are allowed. This is rare for Ozempic but exists in some Medicaid programs.

Solution: Schedule one in-person visit with a local provider, get the initial prescription, then switch to telehealth for refills and monitoring.

Situation 2: You need brand-name Ozempic and your insurance PA keeps getting denied. Telehealth platforms have limited ability to fight complex PA denials, especially if the denial is based on formulary restrictions or step-therapy requirements.

Solution: Work with an in-person endocrinologist or diabetes specialist who has dedicated PA staff. They can submit more detailed appeals with supporting documentation.

Situation 3: You have a contraindication that requires specialist evaluation. If you have a history of pancreatitis, gastroparesis, or thyroid nodules, a telehealth provider may decline to prescribe and refer you to a specialist.

Solution: See an endocrinologist in person for evaluation. If cleared, you can return to telehealth for ongoing management.

Situation 4: You're on Medicare and need the lowest possible cost. Medicare doesn't cover compounded semaglutide, and the Novo Nordisk savings card doesn't apply to Medicare patients. Your best option is brand-name Ozempic through Medicare Part D, but copays are often $200 to $500 monthly.

Solution: Apply for the Novo Nordisk Patient Assistance Program (PAP) if your income is below 400% of federal poverty level. The PAP provides free Ozempic for up to 12 months. Your provider (telehealth or in-person) can submit the application on your behalf.

Situation 5: You want the pre-filled pen convenience and have good insurance. Compounded semaglutide comes in vials requiring manual injection with a syringe. If you strongly prefer the Ozempic pen and your insurance copay is under $100 per month, brand-name is the better choice.

Solution: Use a telehealth platform that prescribes brand-name and routes to your pharmacy, or see an in-person provider.

The decision tree: if you have insurance that covers Ozempic and a copay under $150, pursue brand-name through traditional channels. If you're paying cash or your copay is over $200, compounded semaglutide through telehealth is almost always cheaper.

Red flags: how to spot illegal online pharmacies

The FDA estimates that 96% of online pharmacies operate illegally (FDA Internet Pharmacy Warning 2024). Here's how to identify them:

Red flag 1: No prescription required. Any site that sells Ozempic or semaglutide "with just a questionnaire" or "no doctor visit needed" is illegal. The questionnaire must be reviewed by a licensed provider who issues a prescription.

Red flag 2: Prices far below market. Brand-name Ozempic retails for $900 to $1,100 per pen. If a website offers it for $200 to $400 with "free shipping from overseas," it's counterfeit or diverted.

Red flag 3: No U.S. pharmacy license verification. Legitimate pharmacies display their state pharmacy license number and are verified by the National Association of Boards of Pharmacy (NABP). Check the NABP's safe pharmacy list at safe.pharmacy.

Red flag 4: Ships from outside the U.S. It's illegal to import prescription medications into the U.S. for personal use without FDA approval. Sites shipping from Canada, India, or "international warehouses" are breaking federal law.

Red flag 5: No provider contact information. You should be able to contact the prescribing provider. If the site has no provider names, no medical licenses listed, and no way to reach a clinician, it's not legitimate.

Red flag 6: Spelling and grammar errors. Professional telehealth platforms have polished websites. Scam sites often have broken English, inconsistent branding, and low-quality design.

Red flag 7: Cryptocurrency-only payment. Legitimate platforms accept credit cards and process through standard payment systems. Scam sites often require Bitcoin or wire transfer to avoid traceability.

What to do if you've already ordered from a suspicious site:

• Do not inject the product
• Report the website to the FDA's MedWatch program
• Dispute the charge with your credit card company
• Contact your state board of pharmacy

The FDA seized $46 million worth of counterfeit semaglutide in 2025, much of it sold through illegal online pharmacies (FDA Criminal Investigations 2025). The counterfeit products contained incorrect doses, bacterial contamination, or no active ingredient at all.

FAQ

Can you get Ozempic online without seeing a doctor? No. Federal law requires a valid patient-provider relationship before any prescription can be issued. A licensed provider must evaluate your medical history and determine that Ozempic is appropriate. This can happen via telehealth video or asynchronous review, but a provider evaluation is non-negotiable.

Is it legal to buy Ozempic online? Yes, if you obtain it through a legitimate telehealth platform with a valid prescription. It's illegal to buy Ozempic from websites that don't require a prescription or that ship from outside the U.S. without FDA approval.

How much does Ozempic cost through telehealth? If you use insurance, the cost is the same as in-person prescriptions (typically $25 to $500 per month depending on your plan). If you pay cash for compounded semaglutide through a telehealth platform, expect $179 to $399 per month. Brand-name Ozempic cash price is $940 to $1,150 per month.

Do telehealth platforms accept insurance for Ozempic? Some do, some don't. Platforms that prescribe brand-name Ozempic and route to traditional pharmacies work with insurance. Platforms that offer compounded semaglutide typically operate on a cash-pay model and don't accept insurance.

Can I use my Novo Nordisk savings card with a telehealth prescription? Yes. The savings card works with any valid Ozempic prescription, whether from telehealth or in-person. Present the card at the pharmacy along with your insurance card. Eligible patients pay as low as $25 per month.

How long does it take to get Ozempic through telehealth? For brand-name Ozempic, expect 3 to 10 days (provider review 1 to 3 days, pharmacy processing and pickup or shipping 2 to 7 days). For compounded semaglutide, expect 5 to 7 days total (provider review 1 to 2 days, compounding and shipping 3 to 5 days).

What's the difference between online Ozempic and compounded semaglutide? Ozempic is the FDA-approved brand-name product manufactured by Novo Nordisk, dispensed as a pre-filled pen. Compounded semaglutide is a non-FDA-approved preparation made by a compounding pharmacy, dispensed as a vial with syringes. Both contain semaglutide, but they're not interchangeable.

Will my doctor know if I get Ozempic through telehealth? Only if you tell them or if they have access to your pharmacy records through a shared health system. Telehealth prescriptions don't automatically notify your primary care provider. You should inform your regular doctor about any new medications to avoid drug interactions.

Can I get Ozempic online if I don't have diabetes? It depends on the provider and your medical profile. Ozempic is FDA-approved only for type 2 diabetes, but providers can prescribe it off-label for weight management if you meet clinical criteria (typically BMI above 27 with a weight-related condition, or BMI above 30). Many insurance plans won't cover off-label use.

Is compounded semaglutide as effective as brand-name Ozempic? Compounded semaglutide contains the same active ingredient (semaglutide) but hasn't undergone the same FDA approval process or bioequivalence testing. Clinical effectiveness appears similar based on patient-reported outcomes, but head-to-head studies don't exist. Individual response varies.

What happens if I have side effects from telehealth-prescribed Ozempic? Contact the prescribing provider immediately through the platform's messaging system or phone support. Legitimate platforms have provider availability for urgent questions. Severe side effects (persistent vomiting, severe abdominal pain, vision changes) require emergency medical attention.

Can I switch from in-person Ozempic to telehealth refills? Yes. If you're already on Ozempic prescribed by an in-person provider, many telehealth platforms can take over refill management. You'll complete an intake documenting your current dose, response, and side effects. The telehealth provider reviews and continues the prescription if appropriate.

Sources

1. Patel R et al. Prior Authorization Approval Rates for GLP-1 Receptor Agonists in Commercial Insurance Plans. Diabetes Care. 2025.
2. FDA. Warning Letters and Test Results for Pharmaceutical Products Containing Semaglutide. FDA Enforcement Report. 2025.
3. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
4. Ryan Haight Online Pharmacy Consumer Protection Act of 2008. Public Law 110-425. 2008.
5. FDA. Counterfeit Semaglutide Products Seized in 2025. FDA Criminal Investigations. 2025.
6. National Association of Boards of Pharmacy. Internet Pharmacy Compliance Standards. NABP. 2024.
7. Davies M et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet. 2021.
8. FDA. FDA Drug Safety Communication: FDA warns about counterfeit semaglutide. FDA Safety Alerts. 2024.
9. American Diabetes Association. Standards of Medical Care in Diabetes - 2026. Diabetes Care. 2026.
10. Novo Nordisk. Ozempic (semaglutide) injection Prescribing Information. 2024.
11. Centers for Medicare & Medicaid Services. Medicare Part D Coverage Determination and Appeals. CMS. 2025.
12. Federation of State Medical Boards. Telemedicine Policies by State. FSMB. 2026.
13. Garvey WT et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine. 2022.
14. FDA. Compounding and the FDA: Questions and Answers. FDA Guidance. 2024.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk A/S. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk, Eli Lilly, or any other pharmaceutical manufacturer.